The article "Frailty Assessment in the Cardiovascular Care of Older Adults" by Afilalo et al. discusses the importance of frailty assessment in cardiovascular medicine, particularly in older adults with cardiovascular disease (CVD). Frailty, a biological syndrome characterized by decreased physiological reserve and vulnerability to stressors, is associated with increased mortality and morbidity across various CVD conditions. The authors review the existing evidence on frailty and propose strategies for integrating frailty assessment into clinical practice. They highlight the need for validated frailty tools, such as the Fried scale and the Short Physical Performance Battery (SPPB), and emphasize the importance of considering frailty in decision-making processes, such as cardiac surgery and transcatheter aortic valve replacement (TAVI). The article also addresses the role of frailty in subclinical CVD, heart failure, and acute coronary syndromes, and discusses the potential benefits of interventions like cardiac rehabilitation. Finally, the authors outline high-yield clinical scenarios for frailty assessment and future research directions, emphasizing the need for more robust frailty tools and therapeutic interventions.The article "Frailty Assessment in the Cardiovascular Care of Older Adults" by Afilalo et al. discusses the importance of frailty assessment in cardiovascular medicine, particularly in older adults with cardiovascular disease (CVD). Frailty, a biological syndrome characterized by decreased physiological reserve and vulnerability to stressors, is associated with increased mortality and morbidity across various CVD conditions. The authors review the existing evidence on frailty and propose strategies for integrating frailty assessment into clinical practice. They highlight the need for validated frailty tools, such as the Fried scale and the Short Physical Performance Battery (SPPB), and emphasize the importance of considering frailty in decision-making processes, such as cardiac surgery and transcatheter aortic valve replacement (TAVI). The article also addresses the role of frailty in subclinical CVD, heart failure, and acute coronary syndromes, and discusses the potential benefits of interventions like cardiac rehabilitation. Finally, the authors outline high-yield clinical scenarios for frailty assessment and future research directions, emphasizing the need for more robust frailty tools and therapeutic interventions.